Page last updated: 2024-10-23

baclofen and Alzheimer Disease

baclofen has been researched along with Alzheimer Disease in 7 studies

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research Excerpts

ExcerptRelevanceReference
"The use of baclofen, a structural analog of gamma-aminobutyric acid (GABA), is described in the treatment of a patient with tardive dystonia."7.67Baclofen treatment in a patient with tardive dystonia. ( Allen, A; Lux, WE; Rosse, RB, 1986)
"The use of baclofen, a structural analog of gamma-aminobutyric acid (GABA), is described in the treatment of a patient with tardive dystonia."3.67Baclofen treatment in a patient with tardive dystonia. ( Allen, A; Lux, WE; Rosse, RB, 1986)
"They have been of value in treating pain of cancer and spasticity through spinal subarachnoid catheters."2.37Drug pumps for treatment of neurologic diseases and pain. ( Penn, RD, 1985)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pilipenko, V1
Narbute, K1
Beitnere, U1
Rumaks, J1
Pupure, J1
Jansone, B1
Klusa, V1
Chumakov, I1
Nabirotchkin, S1
Cholet, N1
Milet, A1
Boucard, A1
Toulorge, D1
Pereira, Y1
Graudens, E1
Traoré, S1
Foucquier, J1
Guedj, M1
Vial, E1
Callizot, N1
Steinschneider, R1
Maurice, T1
Bertrand, V1
Scart-Grès, C1
Hajj, R1
Cohen, D1
Wang, SJ1
Huang, CC1
Gean, PW1
Crystal, HA1
Chu, DC1
Penney, JB1
Young, AB1
Penn, RD1
Rosse, RB1
Allen, A1
Lux, WE1

Reviews

1 review available for baclofen and Alzheimer Disease

ArticleYear
Drug pumps for treatment of neurologic diseases and pain.
    Neurologic clinics, 1985, Volume: 3, Issue:2

    Topics: Alzheimer Disease; Baclofen; Bethanechol; Bethanechol Compounds; Catheters, Indwelling; Chronic Dise

1985

Other Studies

6 other studies available for baclofen and Alzheimer Disease

ArticleYear
Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin-induced Alzheimer's disease.
    European journal of pharmacology, 2018, Jan-05, Volume: 818

    Topics: Alzheimer Disease; Animals; Baclofen; Brain; Cognition; Disease Models, Animal; Dose-Response Relati

2018
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.
    Scientific reports, 2015, Jan-08, Volume: 5

    Topics: Acamprosate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apop

2015
Investigations on the mechanism of tetrahydro-9-aminoacridine-induced presynaptic inhibition in the rat amygdala.
    Neuroscience, 1996, Volume: 70, Issue:2

    Topics: 4-Aminopyridine; Alzheimer Disease; Amygdala; Animals; Baclofen; Dose-Response Relationship, Drug; M

1996
Baclofen therapy may be associated with chorea in Alzheimer's disease.
    Annals of neurology, 1990, Volume: 28, Issue:6

    Topics: Aged; Alzheimer Disease; Baclofen; Chorea; Humans; Male

1990
Cortical GABAB and GABAA receptors in Alzheimer's disease: a quantitative autoradiographic study.
    Neurology, 1987, Volume: 37, Issue:9

    Topics: Aged; Alzheimer Disease; Animals; Autoradiography; Baclofen; Binding, Competitive; Frontal Lobe; Hum

1987
Baclofen treatment in a patient with tardive dystonia.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:9

    Topics: Aged; Alzheimer Disease; Baclofen; Dystonia; Female; Haloperidol; Humans

1986